Patents by Inventor Matthew Fraser

Matthew Fraser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating lower urinary tract and related disorders
    Publication number: 20050148587
    Abstract: The invention relates to methods of using Cav2.2 subunit calcium channel modulators, particularly thiazolidinone, oxazolidinone, and imidazolone derivatives, to treat lower urinary tract and related disorders.
    Type: Application
    Filed: November 17, 2004
    Publication date: July 7, 2005
    Applicant: Dynogen Pharmaceuticals, Inc.
    Inventors: Matthew Fraser, Karl Thor, Edward Burgard
  • Thiazolidinone, oxazolidinone, and imidazolone derivatives for treating non-inflammatory gastrointestinal tract disorders
    Publication number: 20050113421
    Abstract: A method is provided for using Cav2.2 subunit calcium channel modulators, particularly thiazolidinone, oxazolidinone, and imidazolone derivatives, to treat non-inflammatory gastrointestinal tract disorders.
    Type: Application
    Filed: November 17, 2004
    Publication date: May 26, 2005
    Applicant: Dynogen Pharmaceuticals, Inc.
    Inventors: Matthew Fraser, Steven Landau, Edward Burgard
  • Methods of treating lower urinary tract disorders using losigamone
    Publication number: 20050107353
    Abstract: The invention relates to methods of using sodium channel modulators, preferably Losigamone or a pharmaceutically acceptable salt, enantiomer, analog, ester, amide, prodrug, metabolite, or derivative thereof, to treat painful and non-painful lower urinary tract disorders, particularly painful and non-painful overactive bladder with and/or without loss of urine.
    Type: Application
    Filed: October 14, 2004
    Publication date: May 19, 2005
    Applicant: Dynogen Pharmaceuticals, Inc.
    Inventors: Edward Burgard, Karl Thor, Matthew Fraser
  • Methods of treating non-painful bladder disorders using alpha2delta subunit calcium channel modulators
    Publication number: 20050054725
    Abstract: A method is provided for treatment of non-painful bladder disorders, particularly non-painful overactive bladder without loss of urine. The method comprises administration of an ?2? subunit calcium channel modulator, including gabapentin, pregabalin, GABA analogs, fused bicyclic or tricyclic amino acid analogs of gabapentin, amino acid compounds, and other compounds that interact with the ?2? calcium channel subunit.
    Type: Application
    Filed: August 18, 2004
    Publication date: March 10, 2005
    Applicant: Dynogen Pharmaceuticals, Inc.
    Inventors: Karl Thor, Edward Burgard, Matthew Fraser
  • Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators
    Publication number: 20050026835
    Abstract: A method is provided for using Cav2.2 subunit calcium channel modulators to treat non-inflammatory gastrointestinal tract disorders.
    Type: Application
    Filed: June 10, 2004
    Publication date: February 3, 2005
    Applicant: Dynogen Pharmaceuticals, Inc.
    Inventors: Matthew Fraser, Steven Landau, Edward Burgard
  • Method of treating lower urinary tract disorders
    Publication number: 20050026909
    Abstract: The invention relates to a method of treating at least one symptom of a lower urinary tract disorder in a subject in need of treatment wherein the symptom is selected from the group consisting of urinary frequency, urinary urgency, urinary urge incontinence, nocturia and enuresis. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity.
    Type: Application
    Filed: June 7, 2004
    Publication date: February 3, 2005
    Inventors: Steven Landau, Cheryl Miller, Matthew Fraser
  • Method of treating lower urinary tract disorders
    Publication number: 20050020577
    Abstract: The invention relates to a method of treating at least one symptom of a lower urinary tract disorder in a subject in need of treatment wherein the symptom is selected from the group consisting of urinary frequency, urinary urgency, urinary urge incontinence, nocturia and enuresis. The method comprises administering to a subject in need of treatment a therapeutically effective amount of a compound that has 5-HT3 receptor antagonist activity and NorAdrenaline Reuptake Inhibitor (NARI) activity.
    Type: Application
    Filed: June 7, 2004
    Publication date: January 27, 2005
    Inventors: Steven Landau, Cheryl Miller, Matthew Fraser